Expression of programmed death ligand-1 predicts poor outcome in nasopharyngeal carcinoma

Programmed death ligand-1 (PD-L1) is a potentially important tumor immunotherapy target. However, whether PD-L1 expression is associated with survival in nasopharyngeal carcinoma (NPC) remains controversial. The aim of the present study was to investigate the association between PD-L1 expression and...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Ying-Fei, Ding, Jian-Wu, Liao, Ling-Min, Zhang, Zhi-Lin, Liao, Shou-Sheng, Wu, Ying, Zhou, Dan-Yang, Liu, An-Wen, Huang, Long
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2017
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5530303/
https://www.ncbi.nlm.nih.gov/pubmed/28781814
http://dx.doi.org/10.3892/mco.2017.1318

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5530303/
https://www.ncbi.nlm.nih.gov/pubmed/28781814
http://dx.doi.org/10.3892/mco.2017.1318

Ejemplares similares